Rheumatoid Arthritis Clinical Trials in Chicago

Showing 961-980 of 3,890 trials

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

NCT05367960

This is a 4-year, open-label extension (OLE) study for subjects completing one of two double-blind clinical trials with BPN14770, Study BPN14770-CNS-301 (in adult males) and Study BPN14770-CNS-204 (in adolescent males).

Fragile X Syndrome

Tetra Discovery Partners314 participantsStarted Nov 2022

Irvine, California, United States • Orange, California, United States • Sacramento, California, United States +14 more locations

RECRUITING2.2 miles

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

NCT05550298

The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recently received a hematopoietic cell transplant (HCT) or a solid organ transplant (SOT). Primary Objective To determine if pre-transplant screening for respiratory viral load predicts RVI within 1- year post-transplant among survivors. Secondary Objectives: * To develop and validate a classifier based on pre-transplant immunological profile predictive of developing an acute respiratory viral infection (aRVI), with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors. * To develop and validate a classifier based on Day +100 post-transplant immunological profiles predictive of developing an acute respiratory viral infection (aRVI),with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors .

Hematopoietic Cell TransplantSolid Organ TransplantRespiratory Viral Infection

Arkansas Children's Hospital Research Institute2,000 participantsStarted Dec 2022

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Washington D.C., District of Columbia, United States +24 more locations

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Rheumatoid Arthritis Trials in Other Cities

Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

Long-Term Outcomes of Early Communication Intervention for Deaf/Hard of Hearing Toddlers

Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Improving Outcomes Assessment in Chronic GVHD

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

Hyperbaric Oxygen Brain Injury Treatment Trial

Complex Aneurysm Registry - Real-World Evidence Data Collection Intracranial Aneurysm Treatment Devices

Biobank For MS And Other Demyelinating Diseases

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial

Other Conditions in Chicago